Long-term advanced cholangiocarcinoma survivor with single-agent capecitabine

J BUON. 2012 Oct-Dec;17(4):796.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use*
  • Bile Duct Neoplasms / drug therapy*
  • Bile Duct Neoplasms / mortality
  • Bile Ducts, Intrahepatic*
  • CA-19-9 Antigen / blood
  • Capecitabine
  • Cholangiocarcinoma / drug therapy*
  • Cholangiocarcinoma / mortality
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / therapeutic use
  • Female
  • Fluorouracil / analogs & derivatives*
  • Fluorouracil / therapeutic use
  • Humans
  • Middle Aged
  • Survivors

Substances

  • Antimetabolites, Antineoplastic
  • CA-19-9 Antigen
  • Deoxycytidine
  • Capecitabine
  • Fluorouracil